Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease (Q87389508)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

chronic idiopathic myelofibrosis

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Rosanny Espinal-Witter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Julia Turbiner Geyer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Julia Steinhilber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Irina Bonzheim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Daniel M Knowles

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Falko Fend

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Attilio Orazi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

28 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

204-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL).

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Bone marrow histopathology in myeloproliferative disorders--current diagnostic approach

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Risk factors for leukemic transformation in patients with primary myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Prognostication in primary myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

The detection of CD14 and CD16 in paraffin-embedded bone marrow biopsies is useful for the diagnosis of chronic myelomonocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Comparative analysis of detecting monocytic cells and their aberrancy.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

The value of immunohistochemistry for CD14, CD123, CD33, myeloperoxidase and CD68R in the diagnosis of acute and chronic myelomonocytic leukaemias.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Conventional cytogenetics in myelofibrosis: literature review and discussion

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Biclonal expansion and heterogeneous lineage involvement in a case of chronic myeloproliferative disease with concurrent MPLW515L/JAK2V617F mutation.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

JAK2(V617F) mutation in myelodysplastic syndrome (MDS) with del(5q) arises in genetically discordant clones

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.165

7 January 2021

10.1038/MODPATHOL.2012.165

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23018876%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference